Total Payments
$98,474
2024 Payments
$26,588
Companies
48
Transactions
834
Medicare Patients
1,127
Medicare Billing
$87,775
Payment Breakdown by Category
Other$57,925 (58.8%)
Food & Beverage$17,621 (17.9%)
Consulting$16,470 (16.7%)
Travel$6,118 (6.2%)
Education$306.01 (0.3%)
Gifts$33.57 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,525 | 29 | 58.4% |
| Food and Beverage | $17,621 | 755 | 17.9% |
| Consulting Fee | $16,470 | 12 | 16.7% |
| Travel and Lodging | $6,118 | 15 | 6.2% |
| Honoraria | $400.00 | 1 | 0.4% |
| Education | $306.01 | 21 | 0.3% |
| Gift | $33.57 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $37,214 | 61 | $0 (2024) |
| PFIZER INC. | $32,012 | 126 | $0 (2024) |
| Helsinn Therapeutics (U.S.), Inc. | $5,337 | 13 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $4,466 | 18 | $0 (2024) |
| ABBVIE INC. | $4,205 | 88 | $0 (2024) |
| Galderma Laboratories, L.P. | $2,160 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,030 | 36 | $0 (2024) |
| GENZYME CORPORATION | $956.86 | 27 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $824.13 | 32 | $0 (2024) |
| Encore Dermatology Inc. | $810.21 | 34 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,588 | 115 | Dermavant Sciences, Inc. ($19,228) |
| 2023 | $14,311 | 86 | Dermavant Sciences, Inc. ($11,764) |
| 2022 | $9,481 | 87 | Dermavant Sciences, Inc. ($6,222) |
| 2021 | $1,408 | 58 | GENZYME CORPORATION ($310.14) |
| 2020 | $4,174 | 38 | PFIZER INC. ($3,662) |
| 2019 | $14,789 | 110 | PFIZER INC. ($7,257) |
| 2018 | $15,810 | 191 | PFIZER INC. ($11,482) |
| 2017 | $11,911 | 149 | PFIZER INC. ($9,106) |
All Payment Transactions
834 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: OSTEOARTHRITIS | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.56 | General |
| 11/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,400.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $54.72 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Travel and Lodging | In-kind items and services | $916.96 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Travel and Lodging | In-kind items and services | $824.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Travel and Lodging | In-kind items and services | $274.80 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $122.93 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 313 | 521 | $55,823 | $26,466 |
| 2022 | 10 | 291 | 479 | $51,089 | $24,949 |
| 2021 | 8 | 269 | 415 | $42,163 | $20,934 |
| 2020 | 8 | 254 | 329 | $36,537 | $15,426 |
Total Patients
1,127
Total Services
1,744
Medicare Billing
$87,775
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 130 | $16,676 | $8,164 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 84 | $15,201 | $6,860 | 45.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 37 | $5,447 | $2,817 | 51.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $4,870 | $2,473 | 50.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,833 | $1,302 | 45.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 30 | $2,400 | $1,190 | 49.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 13 | 15 | $2,508 | $1,176 | 46.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 24 | $2,303 | $1,014 | 44.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 18 | 26 | $2,281 | $998.59 | 43.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 14 | 82 | $792.94 | $435.21 | 54.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 51 | $510.00 | $36.71 | 7.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 138 | $17,239 | $8,843 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 66 | $11,651 | $5,973 | 51.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 34 | 41 | $5,958 | $2,964 | 49.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $5,357 | $2,370 | 44.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 15 | 20 | $3,344 | $1,615 | 48.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 27 | $1,991 | $1,175 | 59.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 21 | 28 | $2,457 | $936.57 | 38.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 15 | 22 | $2,098 | $820.42 | 39.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 11 | 36 | $315.12 | $197.35 | 62.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 23 | 68 | $680.00 | $55.06 | 8.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 136 | $16,320 | $8,138 | 49.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 37 | $5,974 | $3,313 | 55.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 36 | 44 | $6,248 | $3,204 | 51.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $6,168 | $2,760 | 44.7% |
About Dr. Sumayah Taliaferro, MD
Dr. Sumayah Taliaferro, MD is a Specialist healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467658393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sumayah Taliaferro, MD has received a total of $98,474 in payments from pharmaceutical and medical device companies, with $26,588 received in 2024. These payments were reported across 834 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,525).
As a Medicare-enrolled provider, Taliaferro has provided services to 1,127 Medicare beneficiaries, totaling 1,744 services with total Medicare billing of $87,775. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Atlanta, GA
- Active Since 06/26/2007
- Last Updated 07/01/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467658393
Products in Payments
- VTAMA (Drug) $37,214
- EUCRISA (Drug) $32,012
- VALCHLOR (Drug) $5,337
- Zoryve (Drug) $3,246
- COSENTYX (Biological) $1,858
- EPIDUO FORTE (Drug) $1,741
- DUPIXENT (Biological) $1,090
- Impoyz (Drug) $646.53
- RINVOQ (Biological) $604.00
- OPZELURA (Drug) $479.81
- Sumadan Wash (Drug) $474.56
- Cimzia (Drug) $461.26
- Otezla (Drug) $428.88
- SKYRIZI (Biological) $419.05
- TALTZ (Drug) $392.84
- Cloderm Cream (Drug) $364.41
- ENSTILAR (Drug) $357.09
- DORYX (Drug) $332.04
- Humira (Biological) $282.30
- Sotyktu (Drug) $261.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Atlanta
Melhem Solh, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Theresa Jarmuz, M.d, M.D
Specialist — Payments: $98,072
Specialist $98,072
Dr. Scott Solomon, M.d, M.D
Specialist — Payments: $59,894
Specialist $59,894
Dr. Asad Bashey, M.d, M.D
Specialist — Payments: $45,487
Specialist $45,487
Dr. Bronier Costas, M.d, M.D
Specialist — Payments: $45,325
Specialist $45,325
Dr. Larry Hobson, M.d, M.D
Specialist — Payments: $29,823
Specialist $29,823